Sprint Bioscience AB (SPRINT) — Working Capital to Net Assets Ratio
Sprint Bioscience AB (SPRINT) has a Working Capital to Net Assets ratio of 96.8% as of December 2025. Working capital of Skr115.39 Million (current assets of Skr132.87 Million minus current liabilities of Skr17.48 Million) is measured against net assets of Skr119.18 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SPRINT equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sprint Bioscience AB Working Capital to Net Assets (2011–2025)
This chart shows how Sprint Bioscience AB's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 96.8%, reflecting working capital of Skr115.39 Million against net assets of Skr119.18 Million SEK. Check SPRINT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Sprint Bioscience AB (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sprint Bioscience AB from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Sprint Bioscience AB stock valuation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.8% | Skr115.39 Million | Skr119.18 Million | Skr132.87 Million | Skr17.48 Million | ▲ +48.7 pp |
| 2024 | 48.1% | Skr4.46 Million | Skr9.27 Million | Skr37.24 Million | Skr32.78 Million | ▼ -35.7 pp |
| 2023 | 83.8% | Skr23.27 Million | Skr27.77 Million | Skr57.87 Million | Skr34.60 Million | ▼ -7.2 pp |
| 2022 | 91.0% | Skr25.65 Million | Skr28.19 Million | Skr34.88 Million | Skr9.23 Million | ▼ -4.5 pp |
| 2021 | 95.5% | Skr67.25 Million | Skr70.45 Million | Skr75.94 Million | Skr8.68 Million | ▲ +7.8 pp |
| 2020 | 87.7% | Skr8.02 Million | Skr9.14 Million | Skr32.27 Million | Skr24.25 Million | ▲ +4.6 pp |
| 2019 | 83.1% | Skr9.15 Million | Skr11.02 Million | Skr17.38 Million | Skr8.23 Million | ▲ +93.1 pp |
| 2018 | -10.0% | Skr-3.73 Million | Skr37.24 Million | Skr18.31 Million | Skr22.05 Million | ▼ -1.1 pp |
| 2017 | -9.0% | Skr-2.52 Million | Skr28.09 Million | Skr4.88 Million | Skr7.40 Million | ▼ -29.6 pp |
| 2016 | 20.7% | Skr5.89 Million | Skr28.49 Million | Skr26.91 Million | Skr21.03 Million | ▲ +237.3 pp |
| 2015 | -216.7% | Skr-10.44 Million | Skr4.82 Million | Skr14.60 Million | Skr25.04 Million | ▼ -274.8 pp |
| 2014 | 58.1% | Skr11.81 Million | Skr20.32 Million | Skr15.09 Million | Skr3.29 Million | ▲ +84.8 pp |
| 2013 | -26.7% | Skr-897.00K | Skr3.36 Million | Skr907.00K | Skr1.80 Million | ▲ +63.2 pp |
| 2012 | -89.9% | Skr-985.89K | Skr1.10 Million | Skr1.72 Million | Skr2.70 Million | ▼ -85.4 pp |
| 2011 | -4.5% | Skr-90.44K | Skr2.03 Million | Skr513.26K | Skr603.70K | — |